Academic Journal

European Patients' Rights to Be Protected Against Counterfeit Medicines

التفاصيل البيبلوغرافية
العنوان: European Patients' Rights to Be Protected Against Counterfeit Medicines
المؤلفون: Erimia, Cristina Luiza
المصدر: European Journal of Medicine and Natural Sciences; Vol. 2 No. 1 (2019): January - June 2019; 8-13 ; 2601-6400 ; 2601-6397
بيانات النشر: EUSER
سنة النشر: 2019
المجموعة: European Center for Science Education and Research (EUSER): E-Journals
مصطلحات موضوعية: patient rights, European legislation, the European Union, counterfeit medicinal products, public health, legislative initiatives, internal market, legal supply chain
الوصف: Because the falsification of medicines is a global problem, requires increased and effective international coordination and cooperation to ensure the effectiveness of the strategies to combat counterfeiting, especially in relation to the sale of such products on the Internet. In the context of people’s health and life rank foremost among the values and interests protected by the TFEU, this article examines the evolution of the legislative process regulating the internal market for medicinal products in order to ensure a high level of protection of public health against falsified medicines and to present the legislative initiatives that have been taken at EU level taking account of new risk profiles, measures meant to ensure, at the same time, the functioning of the internal market of medicinal products. However, this article aims to address consumers’ right to have access to safe, effective, quality and innovative medicinal products as a right of the European patient. Ensuring the free movement of medicinal products on the EU market must not violate or restrict this fundamental right of thepatient.The threat that falsified medicines pose to public health is also recognized by the World Health Organization (WHO), which has established the International Medical Products Anti-Counterfeiting Taskforce ("IMPACT").IMPACT has developed the Principles and Elements for National Legislation against Counterfeit Medical Products, which were endorsed by the IMPACT General Meeting in Lisbon on 12 December 2007.
نوع الوثيقة: article in journal/newspaper
اللغة: English
Relation: https://journals.euser.org/index.php/ejmn/article/view/5079/4933; https://journals.euser.org/index.php/ejmn/article/view/5079
الاتاحة: https://journals.euser.org/index.php/ejmn/article/view/5079
Rights: Copyright (c) 2021 European Journal of Natural Sciences and Medicine ; https://creativecommons.org/licenses/by-sa/4.0
رقم الانضمام: edsbas.DDB7D1C1
قاعدة البيانات: BASE